Wednesday, Jul 26 2017 | Time 12:22 Hrs(IST)
image
  • China to convert all giant state companies into joint-stock firms by end-2017
  • Cloudy morning in Delhi, light rain likely
  • Strike by Pakistan fuel tankers enters third day; long queues at stations
  • After IS, Mosul rebuilds monuments, mosques -- and society
  • Lloris frustrated by Tottenham's lack of progress in Europe
  • RS ADJOURNED TILL 12 NOON AFTER UPROAR BY CONGRESS OVER NEHRU GANDHI ISSUE
  • J&K CM’s Grievance Cell disposes off 796 complaints
  • Scientists dim sunlight, suck up carbon dioxide to cool planet
  • Pothole plagued Harare seeks to build climate-resilient roads
  • Suspected Boko Haram militants kidnap 10 oil contractors in northeast Nigeria -NNPC
  • 2 kidnapped jewelers rescued from Jhansi
  • LeT militant arrested in north Kashmir
  • Teenager’s body found from rivulet in Reasi
  • Sensex opens at peak at 32,255.99 pts
  • Major currencies up
Science & Technology Share

Cytoreductive Surgery performed at Jipmer

Cytoreductive Surgery performed at Jipmer

Puducherry, Mar 16 (UNI) In an effort to provide the state of the art health services to the underprivileged, JIPMER has moved a step forward by performing its first Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Department of Surgical Oncology.
According to a Jipmer release here today, the surgery was performed by a team of surgeons led by Dr.
Prasanth Penumadu on a 60-year-old woman with the help of guest faculty Dr.
Saket Mehta from ‘Saifee hospital’ Mumbai, who is one of the pioneers in the procedure in the country.
The anesthesia team was led by Dr.
Srinivasan Swaminathan.
The woman was treated for a type of peritoneal surface malignancy called Pseudomyxomaperitonei, here in January 2017.
The 10-hour long procedure gave a new lease of life to the patient by complete excision of the tumor, which otherwise would have been incurable.
The patient recovered and was discharged three weeks later.
Dr.
K.
Srinivasan, head of the department of Surgical Oncology said “Due to associated high complications, procedures like peritonectomy with HIPEC should be done in specialized centers and JIPMER has taken initiative in performing the same”.
The procedure which would cost about 2-3 lakh was performed free of cost in JIPMER, the release said.
Peritoneal surface malignancies refer to those cancers arising either primarily from the peritoneum, a thin and clear layer lining the inner surface of abdominal wall and viscera (referred to as primary peritoneal malignancy) or has spread to it from a different primary site (secondary peritoneal malignancy).
It is not a disease that is often heard of because it is rare but aggressive.
Until recently, treatment options were limited to offering patients relief from symptoms, with little progress made in offering a cure,the release said.
Advances in medical science have enabled cancer specialists to offer a ray of hope to those suffering from this disease by using a two-step approach to treatment.
The first and the most crucial, surgical eradication of all visible tumor in the abdomen, is called Cytoreductive surgery.
The second involves exposing the abdominal viscera to heated and sterile chemotherapy drugs immediately after surgery termed, HIPEC, a technique initially described by Dr.
Paul Sugarbaker.
The surgery is considered technically demanding and is associated with high morbidity rates, thus necessitating the proper selection of patients and also need to be done in higher specialized centers.
The procedure is shown to improve life span in patients with peritoneal dissemination from cancers of the appendix, large intestine, ovary and peritoneal mesothelioma.
Its role in other cancers is under evaluation in studies worldwide.
The procedure is being performed at very few centers in India.
JIPMER, under the administration of Dr.
S C Parija, is planning to establish dedicated services in the department of Surgical Oncology for the management of peritoneal surface malignancies,the release added.
UNI PAB CS 1741

Yemen

Yemen cholera epidemic slowing after infecting 400,000

By Tom Miles

GENEVA, July 25 (Reuters)  Yemen's cholera outbreak is set to hit 400,000 cases on Tuesday but there are signs the three-month-old epidemic is slowing, according to World Health Organization data analysed by Reuters.

IMA

IMA organises 'Kidney Update 2017'

Panaji, Jul 24 (UNI) State-level CME Kidney Update 2017 event, organised by Indian Medical Association (IMA) Goa, saw experts from all over India and Spain sharing knowledge with Goan doctors about how to manage better patients with kidney ailments.

HIV

HIV and cancer teams double up to seek out new disease killers

By Kate Kelland, Health and Science Correspondent

LONDON, Jul 22 (Reuters) HIV experts at an international conference starting today are keenly courting colleagues in oncology to explore whether advances in harnessing the immune system against cancer can help the search for a cure for AIDS.

Scales

Scales tip in AIDS fight as death rates decline, treatment rates rise

By Kate Kelland, Health and Science Correspondent LONDON, Jul 20 (Reuters) The scales have tipped in the fight against AIDS, with more than half of people infected with HIV now getting treatment and AIDS-related deaths almost halving since 2005, the United Nations said today.

Republican

Republican Senator John McCain diagnosed with brain tumor

Undated, Jul 20 (Reuters) US Republican Senator John McCain has been diagnosed with a brain tumor following surgery to remove a blood clot from above his left eye.

Broken pebbles offer clues to Palaeolithic funeral rituals

Broken pebbles offer clues to Palaeolithic funeral rituals

New Delhi, Feb 9 (UNI) Humans may have ritualistically "killed" objects to remove their symbolic power, some 5,000 years earlier than previously thought, a new international study of marine pebble tools from an Upper Palaeolithic burial site in Italy suggests.

image